CVE-2022-0902
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Improper Neutralization of Special Elements used in a Command ('Command Injection') vulnerability in flow computer and remote controller products of ABB ( RMC-100…
Does this matter?
EPSS puts the probability of exploitation in the next 30 days at 16.7%, higher than 97% of all known CVEs. Patch or mitigate before the next change window.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Improper Neutralization of Special Elements used in a Command ('Command Injection') vulnerability in flow computer and remote controller products of ABB ( RMC-100 (Standard), RMC-100-LITE, XIO, XFCG5 , XRCG5 , uFLOG5 , UDC) allows an attacker who successfully exploited this vulnerability could insert and run arbitrary code in an affected system node.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 16.68% probability · 97th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-22, CWE-77
- Affected
- abb/rmc-100 firmware · abb/rmc-100-lite firmware · abb/xio firmware · abb/xfcg5 firmware · abb/xrcg5 firmware · abb/uflog5 firmware · abb/udc firmware
- Source
- cybersecurity@ch.abb.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.